DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Dugel PU, Koh A, Ogura Y. et al.
HAWK and HARRIER: Phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration.
Ophthalmology 2020;
127: 72-84
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.